The authors underscored the potential of adjuvant pelvic IMRT (post-surgery pelvic radiation therapy) to enhance locoregional ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new Phase III randomized trial.

Between 1991 and 1996, 268 patients were entered onto the study. Two hundred forty-three patients were assessable (127 RT + CT patients and 116 RT patients). Progression-free and overall survival are ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.

A patient who will be referred to as Ms. L in this case study was 34 years old when she presented to the emergency department in January 2012 with severe pain in the right lower quadrant that radiated ...

Please provide your email address to receive an email when new articles are posted on . The PROSPECT trial showed FOLFOX to be noninferior to pelvic chemoradiation before surgery with regard to DFS.

SAN FRANCISCO — Locoregional recurrence after cystectomy for advanced bladder cancer is common and rarely salvageable. Now new findings show that many of those recurrences may be prevented with ...

Whole-pelvic radiation conferred a 67% lower risk of all-cause mortality among patients younger than 65 with unfavorable-risk prostate cancer. Treatment with whole-pelvic radiation therapy (WPRT) may ...

Every year, doctors get better tools to fight cancer. Engineered cancer-killing cells, immunotherapies, targeted drugs, and more are helping clinicians cure more patients. Increasingly, though, ...